Groningen / New York / Rotterdam / Leuven / Cambridge / Neudorf / London / /
Company
IgG / Vulto AG / Genzyme Europe BV / M.L.C. / Slonim AE / Genzyme Corporation / McGraw-Hill / Winkel LP / Engel AG / Ó 2010 Elsevier B.V. / /
Country
Netherlands / Belgium / France / United States / United Kingdom / / /
Facility
Children’s Hospital Radboud University Medical Center / Erasmus MC University Medical Center / Sophia Children’s Hospital / University Hospital Gasthuisberg / National Hospital / Erasmus University Medical Center / / /
IndustryTerm
healthcare research / energy / therapy for patients with Pompe disease / therapy for infantile glycogen storage disease / treatment of Pompe disease / therapy for Pompe disease / /
premedication / surgery / Enzyme Replacement Therapy / /
Organization
Prinses Beatrix Fund / Children’s Hospital Radboud University Medical Center / Department of Clinical Genetics / Department of Pediatrics / Erasmus University Medical Center / Department of Neurology / Charles Dent Metabolic Unit / Erasmus MC-Sophia Children’s Hospital / National Hospital for Neurology and Neurosurgery / Center for Lysosomal and Metabolic Diseases / Medical Research Council / American Thoracic Society / Division of Pediatric Cardiology / MC University Medical Center / Division of Metabolic Diseases and Genetics / Centre for Metabolic Disease / European Union / Department of Pediatric Neurology / Institutional Review Board of the Erasmus MC-Sophia Children / Department of Epidemiology and Biostatistics / /
Person
Vries Lentsch / Ann Neurol / Arch Phys Med / Charles Dent / Van Doorn / Van den Hout / Ned Tijdschr Geneeskd / / /